Zydelig Unión Europea - español - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

EVENING PRIMROSE OIL 500 mg CAPSULA BLANDA Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

evening primrose oil 500 mg capsula blanda

inretail pharma s.a. - oenothera biennis; - capsula blanda - por capsula; oenothera biennis 500.000000 mg; - oenothera biennis l.oil

EVENING PRIMROSE OIL 500 mg CAPSULA BLANDA Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

evening primrose oil 500 mg capsula blanda

global pharmaceutical corporation s.a.c. - aceite de oenothera biennis l.; - capsula blanda - por capsula; aceite de oenothera biennis l. 500.000000 mg; - oenothera biennis l.oil

Celvapan Unión Europea - español - EMA (European Medicines Agency)

celvapan

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vacunas - profilaxis de la influenza causada por el virus a (h1n1) v 2009. celvapan debe ser utilizado de acuerdo con las directrices oficiales.